Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;16(2-3):106-117.
doi: 10.14740/jocmr5097. Epub 2024 Mar 16.

Comparison of Clinical Features, Treatment and Outcomes of Lupus Nephritis Between Patients With Late- and Early-Onset Systemic Lupus Erythematosus: A Controlled Study

Jarukit Mongkolchaiarunya  1   2 , Antika Wongthanee  3 , Nuntana Kasitanon  1 , Worawit Louthrenoo  1
Affiliations

Comparison of Clinical Features, Treatment and Outcomes of Lupus Nephritis Between Patients With Late- and Early-Onset Systemic Lupus Erythematosus: A Controlled Study

Jarukit Mongkolchaiarunya et al. J Clin Med Res. 2024 Mar.

Abstract

Background: Studies have found that late-onset systemic lupus erythematosus (SLE) patients (age at diagnosis ≥ 50 years) had less severe disease and milder clinical course, but with higher organ damage and mortality rate than early-onset ones (age at diagnosis < 50 years). Unfortunately, direct comparison of renal manifestations and treatment outcomes between late- and early-onset SLE patients has been determined rarely. This study aimed to compare lupus nephritis (LN) manifestations, treatment, and outcomes between late- and early-onset in SLE patients.

Methods: Medical records of SLE patients in a lupus cohort at a tertiary care university hospital, seen between January 1994 and June 2020, were reviewed. Late- and early-onset patients were matched with year at SLE diagnosis at a ratio of 1:2 (62 and 124 patients, respectively). Those with LN were identified and analyzed.

Results: At SLE onset and end of the study, LN was identified in 29 and 33 late-onset patients, respectively, and 58 and 90 early-onset patients, respectively. At the end of the study, there were 39 and 214 LN flares in late- and early-onset patients, respectively: giving an incident rate (IR) (95% confidence interval (CI))/100 person-years of LN and active LN flares of 2.00 (0.75 - 5.33) vs. 6.11 (4.32 - 8.64), P = 0.020, and 5.78 (2.75 - 12.12) vs. 18.28 (13.93 - 24.00), P = 0.001, respectively. Late-onset patients received a higher proportion of moderate- to high-dose corticosteroids, but fewer immunosuppressive drugs. In all LN flares, no difference existed between the two groups in serum creatinine, degree of proteinuria, and proportion of patients with nephrotic range proteinuria or rapidly progressive glomerulonephritis, and outcomes in terms of complete, partial or no-remission were similar between them. Mortality rate was higher in late-onset patients (27.27% vs. 6.67%, P = 0.004).

Conclusion: This matched controlled study of year at SLE diagnosis showed that late-onset SLE patients had lower prevalence of LN and LN flares. Although they received fewer immunosuppressive drugs, their renal manifestations and treatment outcomes were no different from those in early-onset patients.

Keywords: Adult; Elderly; Lupus nephritis; Systemic lupus erythematosus; Treatment outcome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart showing the matching process. ACR: American College of Rheumatology; SLE: systemic lupus erythematosus.
Figure 2
Figure 2
Kaplan-Meier curve showing mortality rate among late- and early-onset SLE patients. SLE: systemic lupus erythematosus.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Mok CC. Prognostic factors in lupus nephritis. Lupus. 2005;14(1):39–44. doi: 10.1191/0961203305lu2057oa. - DOI - PubMed
    1. Hocaoglu M, Valenzuela-Almada MO, Dabit JY, Osei-Onomah SA, Chevet B, Giblon RE, Zand L. et al. Incidence, prevalence, and mortality of lupus nephritis: a population-based study over four decades using the lupus midwest network. Arthritis Rheumatol. 2023;75(4):567–573. doi: 10.1002/art.42375. - DOI - PMC - PubMed
    1. Ocampo-Piraquive V, Nieto-Aristizabal I, Canas CA, Tobon GJ. Mortality in systemic lupus erythematosus: causes, predictors and interventions. Expert Rev Clin Immunol. 2018;14(12):1043–1053. doi: 10.1080/1744666X.2018.1538789. - DOI - PubMed
    1. Riveros Frutos A, Holgado S, Sanvisens Berge A, Casas I, Olive A, Lopez-Longo FJ, Calvo-Alen J. et al. Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER) Rheumatology (Oxford) 2021;60(4):1793–1803. doi: 10.1093/rheumatology/keaa477. - DOI - PubMed
    1. Medhat BM, Behiry ME, Sobhy N, Farag Y, Marzouk H, Mostafa N, Khalifa I. et al. Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort. Clin Rheumatol. 2020;39(2):435–442. doi: 10.1007/s10067-019-04776-y. - DOI - PubMed

LinkOut - more resources